Actions

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
Investor Presentation
Q4 FY26
Healthcare Equipment & Supplies
Medical Equipment & Supplies
1,238 Cr
Low Risk
22.2
45.4
1.7
2.5
600.00
431.00
Sales CAGR
Profit CAGR
ROE
ROCE
Q-Line Biotech Ltd (QLINE) is currently trading at 532.80 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Q-Line Biotech Ltd operates in the its sector sector. Review the About Company section on this page to understand its business model, revenue streams, and key products or services.
Over the past 52 weeks, Q-Line Biotech Ltd has traded between a low of ₹431.00 and a high of ₹600.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Q-Line Biotech Ltd has a market capitalization of approximately 1,238.38. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Q-Line Biotech Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 22.22 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 1,238.38 Cr, Q-Line Biotech Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Q-Line Biotech Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Q-Line Biotech Ltd is 22.22. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Bearish
0
Neutral
10
Bullish
4
Bearish
9
Neutral
22
Bullish
15
Bearish
9
Neutral
12
Bullish
11
Bearish
0
Neutral
10
Bullish
4
Bearish
0
Neutral
10
Bullish
4
Bearish
9
Neutral
12
Bullish
11
Bearish
9
Neutral
12
Bullish
11
Bearish
9
Neutral
12
Bullish
11